Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pierian Biosciences

Request full access

A privately held life sciences company offering the development and delivery of innovative, treatment-directing information

Franklin, United StatesFounded 2003Biotech & Life Sciences

About Pierian Biosciences

Pierian Biosciences, established in 2008 and formerly known as DiaTech Oncology, is a privately held life sciences company headquartered in Franklin, Tennessee. The company operates as a diagnostic development and laboratory service provider, focusing on personalized cancer intelligence to guide treatment decisions for patients with cancer and autoimmune diseases. Robert Henry joined the company as CEO in 2013, bringing over 25 years of healthcare management experience to steer the company's growth in the personalized cancer care market. A significant milestone in the company's history is its international expansion, which involved establishing its first UK laboratory in Liverpool's Science Park in October 2022, a project involving over £60 million in investment. This strategic move was designed to foster collaboration with key medical opinion leaders and access the UK's research facilities, with Chief Scientific Officer Norman Purvis relocating to manage the new site.

The company's business model is centered on providing clinically actionable diagnostic information to healthcare providers. It serves biopharmaceutical companies and clinicians, offering support from pre-clinical research through Phase IV clinical trials. Revenue is generated through its laboratory and diagnostic services that help personalize treatment strategies, aiming to improve patient outcomes and lower healthcare costs. Pierian Biosciences has secured substantial funding to support its operations and growth, raising a total of $76.2 million over three rounds, including a significant Series C funding of $75 million in 2015.

Pierian Biosciences' core offerings are its advanced technology platforms: ChemoINTEL™ and ImmunoINTEL™. The ChemoINTEL™ platform is a chemosensitivity assay that measures the real-time apoptotic response of a patient's isolated tumor cells to various cytotoxic agents and targeted therapies. This platform utilizes an automated, high-throughput imaging system to provide a single-cell functional analysis, helping to identify the most effective chemotherapy drugs for an individual. The ImmunoINTEL™ platform is a flow cytometry-based system that provides a detailed characterization of the tumor microenvironment and the immune landscape. It quantifies tumor and immune cell populations and analyzes their functional status, which is crucial for guiding the selection of immunotherapies. Together, these platforms support the development of personalized treatment plans by determining which therapeutic agents are most likely to be effective against a specific patient's cancer.

Source: Dealroom company data

Pierian Biosciences in the Franklin ecosystem

Live from Dealroom

The Pierian Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom83.3%
🇺🇸 United States16.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pierian Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pierian Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.